Pediatric Infectious Disease

Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2020 ) > List of Articles


Management of Children with Community-acquired Pneumonia: A Review of Literature

Ilin Kinimi, Supriya S Shinde, Neha M Rao, Archana Mahalingam

Citation Information : Kinimi I, Shinde SS, Rao NM, Mahalingam A. Management of Children with Community-acquired Pneumonia: A Review of Literature. Pediatr Inf Dis 2020; 2 (3):99-106.

DOI: 10.5005/jp-journals-10081-1274

License: CC BY-NC 4.0

Published Online: 28-09-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Community-acquired pneumonia in children is a common infection but can be potentially serious in some, leading to hospitalization in those with severe or complicated pneumonias. Diagnosis can be made with appropriate history and relevant clinical examination. Viral and Streptococcus pneumoniae infections remain the most common cause of CAP in preschool children, whereas Mycoplasma pneumoniae can present more commonly in older children. Treatment with the appropriate antibiotics is crucial, especially with the increasing prevalence of viral and bacterial co-infections as well as emerging antibiotic resistance. Appropriate dosage and duration of antibiotics are determined by the severity or complications involved. In addition, immunization is extremely important for prevention of CAP in children.

PDF Share
  1. World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: Evidence summaries 2014. Available from;jsessionid=A5477DC17AF6B6A9D0DF233BB1E37851?sequence=1. Accessed on April 10, 2020.
  2. Don M, Canciani M, Korppi M. Community-acquired pneumonia in children: What's old? what's new? Acta Paediatr 2010;99(11):1602–1608. Available from: on April 12, 2020.
  3. Harris M, Clark J, Coote N, et al. British thoracic society guidelines for the management of community acquired pneumonia in children: Update 2011. Thorax 2011;66(2):Available from Accessed on April 10, 2020.
  4. Messinger AI, Kupfer O, Hurst A, et al. Management of pediatric community-acquired bacterial pneumonia. Pediatr Rev 2017;38(9):394. DOI: 10.1542/pir.2016-0183Available from: Accessed on April 09, 2020.
  5. Cilla G, Oñate E, Perez-Yarza EG, et al. Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection. J Med Virol 2008;80(10):1843–1849. Available from Accessed on April 11, 2020.
  6. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004;113(4):701–707. DOI: 10.1542/peds.113.4.701Available from: Accessed on April 09, 2020.
  7. Leung AKC, Wong AHC, Hon KL. Community-acquired pneumonia in children. Recent Pat Inflamm Allergy Drug Discov 2018;12(2):136–144. DOI: 10.2174/1872213X12666180621163821Available from: Accessed on April 08, 2020.
  8. Salaria M, Singh M. Atypical pneumonia in children. Indian Pediatr 2002;39:259–266. Available from: Accessed on April 10, 2020.
  9. Higdon MM, Le T, O'Brien KL, et al. Association of C-reactive protein with bacterial and respiratory syncytial virus-associated pneumonia among children aged <5 years in the PERCH study. Clin Infect Dis 2017;64(suppl_3):S378–S386. DOI: 10.1093/cid/cix150Available from: Accessed on April 11, 2020.
  10. Schuetz P, Branche A, Mueller B. Low procalcitonin, community acquired pneumonia, and antibiotic therapy – Authors’ reply. Lancet Infectious Diseases 2018;18(5):497–498. DOI: 10.1016/S1473-3099(18)30226-3Available from: Accessed on April 11, 2020.
  11. Principi N, Esposito S. Biomarkers in pediatric community-acquired pneumonia. Int J Mol Sci 2017;18(2):447. DOI: 10.3390/ijms18020447Available from: Accessed on April 11, 2020.
  12. Stockmann C, Ampofo K, Killpack J, et al. Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia. J Pediat Infec Dis Soc 2017. piw091. Available from: Accessed on April 11, 2020.
  13. Rhee C. Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis 2016;4(1):ofw249. DOI: 10.1093/ofid/ofw249Available from: Accessed on April 10, 2020.
  14. Zhang D, Yang D, Makam AN. Utility of blood cultures in pneumonia. Am J Med 2019;132(10):1233–1238. DOI: 10.1016/j.amjmed.2019.03.025Available from: Accessed on April 12, 2020.
  15. Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis 2016;63(3):300–309. DOI: 10.1093/cid/ciw300Available from: Accessed on April 12, 2020.
  16. Pabary R, Balfour-Lynn IM. Complicated pneumonia in children. Breathe 2013;9(3):210–222. DOI: 10.1183/20734735.043012Available from: Accessed on April12, 2020.
  17. Amatya Y, Rupp J, Russell FM, et al. Diagnostic use of lung ultrasound compared to chest radiograph for pneumonia in a resource-limited setting. Int J Emerg Med 2018;11(1):8. DOI: 10.1186/s12245-018-0170-2Published 2018 Mar 12. Available from: Accessed on April 08, 2020.
  18. Bedawi E, Hassan M, Harriss E, et al. S57 Sonographic septations in pleural infection – what do they actually mean? Thorax 2018;73:A35. Available from: Accessed on April 13, 2020.
  19. Andronikou S, Goussard P, Sorantin E. Computed tomography in children with community-acquired pneumonia. Pediatr Radiol 2017;47(11):1431–1440. DOI: 10.1007/s00247-017-3891-0Available from: Accessed on April13, 2020.
  20. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis 2011;53(7):e25–e76. DOI: 10.1093/cid/cir531Available from: Accessed on April 11, 2020.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.